10E8.4/iMab Bispecific Antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 10E8.4/iMab Bispecific Antibody, covering 2025-04-25 to 2025-04-25. Get the full timeline:
Most recent: Clinical Trial Update: 10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults [Phase 1]